blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1036175

EP1036175 - HUMAN BRAIN DERIVED KCNQ2 POTASSIUM CHANNEL [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  13.02.2009
Database last updated on 03.10.2024
Most recent event   Tooltip20.05.2011Lapse of the patent in a contracting state
New state(s): GR		published on 22.06.2011  [2011/25]
Applicant(s)For all designated states
AstraZeneca AB
151 85 Södertälje / SE
[2000/38]
Inventor(s)01 / Aiyar, Jayashree
1800 Concord Pike, P.O. Box 15437
Wilmington, DE 19850-5437 / US
02 / Iannotti, Claudia Ann
1800 Concord Pike, P.O. Box 15437
Wilmington, DE 19850-5437 / US
03 / Christian, Edward Philip
1800 Concord Pike, P.O. Box 15437
Wilmington, DE 19850-5437 / US
04 / Logsdon, Naomi Jean
5573 13th Avenue, South Birmingham
35222 Alabama / US
[2000/50]
Former [2000/38]01 / Aiyar, Jayashree
1800 Concord Pike, P.O. Box 15437
Wilmington, DE 19850-5437 / US
02 / Iannotti, Claudia Ann
1800 Concord Pike, P.O. Box 15437
Wilmington, DE 19850-5437 / US
03 / Christian, Edward Philip
1800 Concord Pike, P.O. Box 15437
Wilmington, DE 19850-5437 / US
04 / Logsdon, Naomi Jean
1800 Concord Pike, P.O. Box 15437
Wilmington, DE 19850-5437 / US
Representative(s)Phillips, Neil Godfrey Alasdair, et al
Astra Zeneca PLC
Global Intellectual Property
Mereside
Alderley Park, Macclesfield
Cheshire SK10 4TG / GB
[N/P]
Former [2000/38]Phillips, Neil Godfrey Alasdair, et al
Astra Zeneca PLC Global Intellectual Property Mereside Alderley Park
Macclesfield Cheshire SK10 4TG / GB
Application number, filing date98960004.411.12.1998
[2000/38]
WO1998GB03720
Priority number, dateGB1997002633913.12.1997         Original published format: GB 9726339
[2000/38]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9931232
Date:24.06.1999
Language:EN
[1999/25]
Type: A1 Application with search report 
No.:EP1036175
Date:20.09.2000
Language:EN
The application published by WIPO in one of the EPO official languages on 24.06.1999 takes the place of the publication of the European patent application.
[2000/38]
Type: B1 Patent specification 
No.:EP1036175
Date:09.04.2008
Language:EN
[2008/15]
Search report(s)International search report - published on:EP24.06.1999
ClassificationIPC:C12N15/12, C07K14/705, C07K16/28, C12N5/10, A61K38/17, G01N33/566
[2000/38]
CPC:
C07K14/705 (EP,US); A61P11/06 (EP); A61P15/06 (EP);
A61P25/00 (EP); A61P25/08 (EP); A61P25/16 (EP);
A61P25/24 (EP); A61P25/28 (EP); A61P3/10 (EP);
A61P35/00 (EP); A61P37/00 (EP); A61P43/00 (EP);
A61P9/00 (EP); A61K38/00 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2000/38]
TitleGerman:AUS DEM MENSCHLICHEN GEHIRN STAMMENDER KCNQ2 KALIUMKANAL[2007/49]
English:HUMAN BRAIN DERIVED KCNQ2 POTASSIUM CHANNEL[2000/38]
French:CANAL POTASSIQUE KCNQ2 EXTRAIT DU CERVEAU HUMAIN[2000/38]
Former [2000/38]MENSCHLICHER GEHIRNSTAMMENDER KCNQ2 KALIUMKANAL
Entry into regional phase13.07.2000National basic fee paid 
13.07.2000Designation fee(s) paid 
13.07.2000Examination fee paid 
Examination procedure22.06.1999Request for preliminary examination filed
International Preliminary Examining Authority: EP
13.07.2000Examination requested  [2000/38]
12.02.2003Despatch of a communication from the examining division (Time limit: M06)
05.12.2003Reply to a communication from the examining division
01.07.2004Despatch of a communication from the examining division (Time limit: M06)
21.02.2005Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
26.04.2005Reply to a communication from the examining division
14.02.2006Despatch of a communication from the examining division (Time limit: M06)
24.08.2006Reply to a communication from the examining division
30.11.2007Communication of intention to grant the patent
26.02.2008Fee for grant paid
26.02.2008Fee for publishing/printing paid
Opposition(s)12.01.2009No opposition filed within time limit [2009/12]
Request for further processing for:26.04.2005Request for further processing filed
26.04.2005Full payment received (date of receipt of payment)
Request granted
10.05.2005Decision despatched
05.12.2003Request for further processing filed
05.12.2003Full payment received (date of receipt of payment)
Request granted
22.12.2003Decision despatched
Fees paidRenewal fee
13.12.2000Renewal fee patent year 03
07.12.2001Renewal fee patent year 04
04.12.2002Renewal fee patent year 05
03.12.2003Renewal fee patent year 06
03.12.2004Renewal fee patent year 07
05.12.2005Renewal fee patent year 08
05.12.2006Renewal fee patent year 09
05.12.2007Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT09.04.2008
BE09.04.2008
CY09.04.2008
DK09.04.2008
FI09.04.2008
NL09.04.2008
GR10.07.2008
PT09.09.2008
IE11.12.2008
LU11.12.2008
MC31.12.2008
[2011/25]
Former [2010/28]AT09.04.2008
BE09.04.2008
CY09.04.2008
DK09.04.2008
FI09.04.2008
NL09.04.2008
PT09.09.2008
IE11.12.2008
LU11.12.2008
MC31.12.2008
Former [2010/06]AT09.04.2008
BE09.04.2008
CY09.04.2008
DK09.04.2008
FI09.04.2008
NL09.04.2008
PT09.09.2008
IE11.12.2008
MC31.12.2008
Former [2009/14]AT09.04.2008
BE09.04.2008
DK09.04.2008
FI09.04.2008
NL09.04.2008
PT09.09.2008
Former [2009/08]AT09.04.2008
DK09.04.2008
FI09.04.2008
NL09.04.2008
PT09.09.2008
Former [2008/49]AT09.04.2008
FI09.04.2008
NL09.04.2008
PT09.09.2008
Cited inInternational search[XY]JPH09191882  ;
 [Y]WO9723598  (UNIV UTAH RES FOUND [US]) [Y] 4,10-13,26,27 * claims 3-6,22,23 *;
 [XY]  - PATENT ABSTRACTS OF JAPAN, (19971128), vol. 097, no. 011, & JP09191882 A 19970729 (JAPAN TOBACCO INC) [X] 1,3,5,29 * abstract * [Y] 2,4,6-13,26-28
 [XY]  - EMPATENT DATABASE Accession number E13516 Yokoyama M. ET AL. 23-JUN-1998 (Rel. 56, Created) Human mRNA for a K+ channel protein, XP002095811 [X] 1,3,5,29 * the whole document * [Y] 2,4,6-13,26-28
 [DX]  - YOKOYAMA M ET AL, "Identification and cloning of neuroblastoma-specific and nerve tissue-specific genes through compiled expression profiles.", DNA RES, OCT 31 1996, 3 (5) P311-20, JAPAN, XP002095807 [DX] 1,3,5 * abstract *

DOI:   http://dx.doi.org/10.1093/dnares/3.5.311
 [X]  - EMHUM1 DATABASE Accession number D82346 Yokoyama M. ET AL. 15-FEB-1997 (Rel. 50, Created) Homo sapiens mRNA for HNSPC, XP002095812 [X] 1,3,5 * the whole document *
 [Y]  - WEI A ET AL, "Eight potassium channel families revealed by the C. elegans genome project.", NEUROPHARMACOLOGY, 1996, 35 (7) P805-29, ENGLAND, XP002095808 [Y] 2,4,6-13,26-28 * abstract *

DOI:   http://dx.doi.org/10.1016/0028-3908(96)00126-8
 [PX]  - BIERVERT C ET AL, "A potassium channel mutation in neonatal human epilepsy.", SCIENCE, JAN 16 1998, 279 (5349) P403-6, UNITED STATES, XP002095809 [PX] 1-3,5-9 * the whole document *

DOI:   http://dx.doi.org/10.1126/science.279.5349.403
 [DPX]  - SINGH NA ET AL, "A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns [see comments]", NAT GENET, JAN 1998, 18 (1) P25-9, UNITED STATES, XP002095810 [DPX] 1-3,5-9 * the whole document *

DOI:   http://dx.doi.org/10.1038/ng0198-25
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.